The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 336: Which patients are not suitable for 1st line EVP in bladder cancer
35 minutes
Posted Jul 24, 2024 at 11:01 am.
0:00
35:35
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Jonathan Rosenberg and a surprise guest discuss comorbidities and treatment-related side effects.
Previous
Episode 335: Novel immune therapies for renal cancer
Next
Episode 337: Updated NCCN Guidelines in RCC
← See all 483 episodes of The Uromigos